Fibrosis markers and ursodeoxycholic acid

被引：0

作者：

Stenner, JMC ^{[1
]}

Jazrawi, RP ^{[1
]}

Ahmed, HA ^{[1
]}

Verma, A ^{[1
]}

Northfield, TC ^{[1
]}

机构：

[1] Univ London St Georges Hosp, Sch Med, Dept Gastroenterol Endocrinol & Metab, London SW17 0RE, England

来源：

BILE ACIDS IN HEPATOBILIARY DISEASE | 2000年 / 110B卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：153 / 158

页数：6

共 27 条

[1] SERUM TYPE-III PROCOLLAGEN PEPTIDE AND LAMININ (LAM-P1) DETECT ALCOHOLIC HEPATITIS IN CHRONIC ALCOHOL ABUSERS [J].

ANNONI, G ;

COLOMBO, M ;

CANTALUPPI, MC ;

KHLAT, B ;

LAMPERTICO, P ;

ROJKIND, M .

HEPATOLOGY, 1989, 9 (05) :693-697

[2]

BABBS C, 1988, LANCET, V1, P1021

[3] SERUM PROCOLLAGEN-III PEPTIDE IN ALCOHOLIC AND OTHER CHRONIC LIVER-DISEASES [J].

BELL, H ;

RAKNERUD, N ;

ORJASAETER, H ;

HAUG, E .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1989, 24 (10) :1217-1222

[4] SERIAL DETERMINATION OF TYPE-III PROCOLLAGEN AMINO PROPEPTIDE SERUM LEVELS IN PATIENTS WITH HISTOLOGICALLY PROGRESSIVE AND NONPROGRESSIVE PRIMARY BILIARY-CIRRHOSIS [J].

BEUKERS, R ;

VANZANTEN, RAA ;

SCHALM, SW .

JOURNAL OF HEPATOLOGY, 1992, 14 (01) :22-29

[5] Serum type III procollagen aminopeptide for assessing liver damage in methotrexate-treated psoriatic patients [J].

Boffa, MJ ;

Smith, A ;

Chalmers, RJG ;

Mitchell, DM ;

Rowan, B ;

Warnes, TW ;

Shomaf, M ;

Haboubi, NY .

BRITISH JOURNAL OF DERMATOLOGY, 1996, 135 (04) :538-544

[6] ALPHA-INTERFERON IN THE TREATMENT OF CHRONIC VIRAL-HEPATITIS - EFFECTS ON FIBROGENESIS SERUM MARKERS [J].

CAPRA, F ;

CASARIL, M ;

GABRIELLI, GB ;

TOGNELLA, P ;

RIZZI, A ;

DOLCI, L ;

COLOMBARI, R ;

MEZZELANI, P ;

CORROCHER, R ;

DESANDRE, G .

JOURNAL OF HEPATOLOGY, 1993, 18 (01) :112-118

[7] THE N-TERMINAL PROPEPTIDE OF COLLAGEN TYPE-III IN SERUM AS A PROGNOSTIC INDICATOR IN PRIMARY BILIARY-CIRRHOSIS [J].

ERIKSSON, S ;

ZETTERVALL, O .

JOURNAL OF HEPATOLOGY, 1986, 2 (03) :370-378

[8] DIFFERENT RESPONSE TO URSODEOXYCHOLIC ACID (UDCA) IN PRIMARY BILIARY-CIRRHOSIS ACCORDING TO SEVERITY OF DISEASE [J].

FLOREANI, A ;

ZAPPALA, F ;

MAZZETTO, M ;

NACCARATO, R ;

PLEBANI, M ;

CHIARAMONTE, M .

DIGESTIVE DISEASES AND SCIENCES, 1994, 39 (01) :9-14

[9] SERUM MARKERS OF HEPATIC FIBROGENESIS IN CHRONIC HEPATITIS TYPE-C TREATED WITH ALFA-2A INTERFERON [J].

GALLORINI, A ;

PLEBANI, M ;

PONTISSO, P ;

CHEMELLO, L ;

MASIERO, M ;

MANTOVANI, G ;

ALBERTI, A .

LIVER, 1994, 14 (05) :257-264

[10] SERUM HYALURONAN AS A MARKER OF LIVER FIBROSIS IN CHRONIC VIRAL HEPATITIS-C - EFFECT OF ALPHA-INTERFERON THERAPY [J].

GUECHOT, J ;

LORIA, A ;

SERFATY, L ;

GIRAL, P ;

GIBOUDEAU, J ;

POUPON, R .

JOURNAL OF HEPATOLOGY, 1995, 22 (01) :22-26

← 1 2 3 →